Business Wire

CSC's 2024 Domain Security Report Finds Drop in Healthcare Domain Security Despite Increase in Prominent Cyber Attacks

29.10.2024 13:00:00 CET | Business Wire | Press release

Share

Additionally, 80% of registered web domains resembling a Forbes Global 2000 brand do not belong to that brand

CSC, an enterprise-class domain registrar and world leader in mitigating domain and domain name system (DNS) threats, today released its fifth annual Domain Security Report that found, in a ranking across 26 Forbes Global 2000 industries, Healthcare Equipment and Services fell seven spots and out of the top five industry ranking it previously held. The drop in ranking from 5th in 2023 to 12th in 2024 stands in stark contrast to the prominent rise in cyber attacks on hospitals and healthcare systems this year.

CSC’s 2024 Domain Security Report analyzes the highest and lowest performing industries based on the adoption of key domain security features like registry lock, CAA records, DNS redundancy, type of registrar, DNSSEC, SPF, DKIM, and DMARC. The top five highest performing industries were Business Services and Supplies, IT Software and Services, Media, Retailing, Hotels, and Technology Hardware and Equipment. The lowest performing industries were Construction, Food and Drink and Tobacco, Food Markets, Materials, and Oil and Gas Operations.

“Many wide-scale cyber attacks like ransomware, phishing, and data breaches can originate at the domain level through fraudulently registered or exploited legitimate domains,” says Jim Stoltzfus, president of CSC’s Digital Brand Services. “The severe rise in malicious attacks against healthcare systems and other critical infrastructure this year is a clear indication for all industries to carefully monitor domain activity and registrations, and to pay much more attention to dormant domains, which may be maliciously registered but not put to use until a cyber attack is launched.”

Additional key insights from CSC’s research include:

  • 80% of registered web domains that resemble a Global 2000 brand do not belong to that brand. Of the 80% of homoglyph (lookalike fake) domains owned by third parties other than the Global 2000 brand owners, CSC found that 42% have MX records (email exchange records) compared with 40% in 2023. MX records can be used to send phishing emails or to intercept email.
  • Use of registry lock has grown by 7 percentage points since 2020, but overall adoption is low at 24%. Registry locks enable end-to-end domain name transaction security to mitigate human error and third-party risk. It’s a highly cost-effective means of protecting domain names against accidental or unauthorized modifications or deletions.
  • 107 of the world’s largest public companies have a domain security score of zero. 5% of the Forbes Global 2000 companies do not deploy any of the recommended domain security measures and therefore have the highest level of risk. Based on CSC’s analysis of the adoption of key domain security measures, a security score of zero indicates no adoption of any measure, leaving those companies at the highest risk of domain security threats.
  • Use of DMARC has grown by 82% since 2020. In 2023, the Anti-Phishing Working Group (APWG) reported a record of almost five million logged phishing attacks, making 2023 the worst year for phishing. This rise in attacks helped increase the adoption of DMARC—an email validation system designed to protect a company’s email domain from being used for spoofing and phishing scams.

CSC’s 2024 Domain Security Report further displays how lax domain security can impact brands and consumers by analyzing how cybercriminals exploited the global reach of the 2024 Paris Olympics. CSC observed a surge in fake Olympic and Paris-related domain name registrations coinciding with the start and end of the Games, which were used to promote counterfeit items, fake tickets, fraudulent streaming sites, and phishing attacks. The targeting of this year’s Olympics provides yet another example of how cybercriminals target trusted brands to launch malicious campaigns. This makes monitoring domain ecosystems globally—including lookalike, dropped, re-registered, or newly registered domain names—a priority in any corporate security posture and online brand strategy to mitigate digital threats.

To learn more about CSC’s proactive and defensive security approach to safeguard domains and brands around the world, download the full 2024 Domain Security Report.

About CSC
CSC is the trusted security and threat intelligence provider of choice for the Forbes Global 2000 and the 100 Best Global Brands (Interbrand®) in enterprise domain names, domain name system (DNS), digital certificate management, as well as digital brand and fraud protection. As global companies make significant investments in their security posture, CSC can help them understand known cybersecurity oversights that exist, and help them secure their online digital assets and brands. By leveraging CSC’s proprietary technology, companies can solidify their security posture to protect against cyber threat vectors targeting their online assets and brand reputation, helping them avoid devastating revenue loss, and significant financial penalties because of policies like the General Data Protection Regulation (GDPR). CSC also provides online brand protection—the combination of online brand monitoring and enforcement activities—taking a holistic approach to digital asset protection, along with fraud protection services to combat phishing. Headquartered in Wilmington, Delaware, USA, since 1899, CSC has offices throughout the United States, Canada, Europe, and the Asia-Pacific region. CSC is a global company capable of doing business wherever our clients are—and we accomplish that by employing experts in every business we serve. Visit cscdbs.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241029131170/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye